Effects of oxcarbazepine and phenytoin on the EEG and cognition in healthy volunteers

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

We studied the EEG and cognitive effects of oxcarbazepine (OXC) and phenytoin (PHT) using a double-blind, randomized, parallel-group design. Thirty-two healthy volunteers received a maximum of 1200 mg of OXC or 360 mg of PHT. EEG and cognitive testing were performed at baseline and after 12 weeks of treatment. For each subject and measure, test-retest Z scores were calculated from regression equations derived from 73 healthy controls. Twenty-six subjects completed the study. Both the OXC and PHT groups had significant slowing of the EEG peak frequency and increased relative theta and delta power. Differences between AEDs (antiepileptic drugs) were not significant. Significant cognitive effects were seen on 5 of 20 measures, primarily measures of motor speed and reaction time. Again, there were no significant differences between AEDs. The only significant difference between AEDs was for the POMS-Vigor scale, favoring OXC. The small sample size may have contributed to the lack of significant differences between AEDs.

Original languageEnglish (US)
Pages (from-to)894-902
Number of pages9
JournalEpilepsy and Behavior
Volume5
Issue number6
DOIs
StatePublished - Dec 2004

Fingerprint

Phenytoin
Anticonvulsants
Cognition
Electroencephalography
Healthy Volunteers
Sample Size
oxcarbazepine
Therapeutics

Keywords

  • Cognition
  • EEG
  • Neurotoxicity
  • Oxcarbazepine
  • Phenytoin

ASJC Scopus subject areas

  • Clinical Neurology
  • Behavioral Neuroscience
  • Neurology

Cite this

Effects of oxcarbazepine and phenytoin on the EEG and cognition in healthy volunteers. / Salinsky, Martin; Spencer, David; Oken, Barry; Storzbach, D.

In: Epilepsy and Behavior, Vol. 5, No. 6, 12.2004, p. 894-902.

Research output: Contribution to journalArticle

@article{eb1cfaa64341465f875a5afb93cc6f2f,
title = "Effects of oxcarbazepine and phenytoin on the EEG and cognition in healthy volunteers",
abstract = "We studied the EEG and cognitive effects of oxcarbazepine (OXC) and phenytoin (PHT) using a double-blind, randomized, parallel-group design. Thirty-two healthy volunteers received a maximum of 1200 mg of OXC or 360 mg of PHT. EEG and cognitive testing were performed at baseline and after 12 weeks of treatment. For each subject and measure, test-retest Z scores were calculated from regression equations derived from 73 healthy controls. Twenty-six subjects completed the study. Both the OXC and PHT groups had significant slowing of the EEG peak frequency and increased relative theta and delta power. Differences between AEDs (antiepileptic drugs) were not significant. Significant cognitive effects were seen on 5 of 20 measures, primarily measures of motor speed and reaction time. Again, there were no significant differences between AEDs. The only significant difference between AEDs was for the POMS-Vigor scale, favoring OXC. The small sample size may have contributed to the lack of significant differences between AEDs.",
keywords = "Cognition, EEG, Neurotoxicity, Oxcarbazepine, Phenytoin",
author = "Martin Salinsky and David Spencer and Barry Oken and D. Storzbach",
year = "2004",
month = "12",
doi = "10.1016/j.yebeh.2004.07.011",
language = "English (US)",
volume = "5",
pages = "894--902",
journal = "Epilepsy and Behavior",
issn = "1525-5050",
publisher = "Academic Press Inc.",
number = "6",

}

TY - JOUR

T1 - Effects of oxcarbazepine and phenytoin on the EEG and cognition in healthy volunteers

AU - Salinsky, Martin

AU - Spencer, David

AU - Oken, Barry

AU - Storzbach, D.

PY - 2004/12

Y1 - 2004/12

N2 - We studied the EEG and cognitive effects of oxcarbazepine (OXC) and phenytoin (PHT) using a double-blind, randomized, parallel-group design. Thirty-two healthy volunteers received a maximum of 1200 mg of OXC or 360 mg of PHT. EEG and cognitive testing were performed at baseline and after 12 weeks of treatment. For each subject and measure, test-retest Z scores were calculated from regression equations derived from 73 healthy controls. Twenty-six subjects completed the study. Both the OXC and PHT groups had significant slowing of the EEG peak frequency and increased relative theta and delta power. Differences between AEDs (antiepileptic drugs) were not significant. Significant cognitive effects were seen on 5 of 20 measures, primarily measures of motor speed and reaction time. Again, there were no significant differences between AEDs. The only significant difference between AEDs was for the POMS-Vigor scale, favoring OXC. The small sample size may have contributed to the lack of significant differences between AEDs.

AB - We studied the EEG and cognitive effects of oxcarbazepine (OXC) and phenytoin (PHT) using a double-blind, randomized, parallel-group design. Thirty-two healthy volunteers received a maximum of 1200 mg of OXC or 360 mg of PHT. EEG and cognitive testing were performed at baseline and after 12 weeks of treatment. For each subject and measure, test-retest Z scores were calculated from regression equations derived from 73 healthy controls. Twenty-six subjects completed the study. Both the OXC and PHT groups had significant slowing of the EEG peak frequency and increased relative theta and delta power. Differences between AEDs (antiepileptic drugs) were not significant. Significant cognitive effects were seen on 5 of 20 measures, primarily measures of motor speed and reaction time. Again, there were no significant differences between AEDs. The only significant difference between AEDs was for the POMS-Vigor scale, favoring OXC. The small sample size may have contributed to the lack of significant differences between AEDs.

KW - Cognition

KW - EEG

KW - Neurotoxicity

KW - Oxcarbazepine

KW - Phenytoin

UR - http://www.scopus.com/inward/record.url?scp=10844278240&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=10844278240&partnerID=8YFLogxK

U2 - 10.1016/j.yebeh.2004.07.011

DO - 10.1016/j.yebeh.2004.07.011

M3 - Article

VL - 5

SP - 894

EP - 902

JO - Epilepsy and Behavior

JF - Epilepsy and Behavior

SN - 1525-5050

IS - 6

ER -